The class II phosphoinositide 3-kinase PI3K-C2β regulates cell migration by a PtdIns(3)P dependent mechanism

Journal of Cellular Physiology

Volumn 205, Issue 3, 2005, Pages 452-462

  Domin, Jan ^a   Harper, Lisa ^a   Aubyn, Deborah ^b   Wheeler, Matthew ^a   Florey, Oliver ^a   Haskard, Dorian ^a   Yuan, Ming ^a   Zicha, Daniel ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; FIBRONECTIN; GUANOSINE TRIPHOSPHATE; HYBRID PROTEIN; ISOENZYME; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE C2BETA; PROTEIN CDC42; PROTEIN SUBUNIT; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; BINDING ASSAY; BIOSYNTHESIS; CELL ADHESION; CELL ASSAY; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSKELETON; ENZYME ACTIVITY; ENZYME ASSAY; FILOPODIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LAMELLIPODIUM; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TIME LAPSE VIDEO MICROSCOPY; TISSUE CULTURE CELL; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; ANIMALS; CATTLE; CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS; CYTOSKELETON; FETAL BLOOD; GUANOSINE TRIPHOSPHATE; HUMANS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RAC GTP-BINDING PROTEINS; RECOMBINANT PROTEINS; TISSUE DISTRIBUTION;

EID: 27744606985     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20478     Document Type: Article

References (63)

1. Arcaro A, Zvelebil MJ, Wallasch C, Ullrich A, Waterfield MD, Domin J. 2000. Class II phosphoinositide 3-kinase are downstream targets of activated polypeptide growth factor receptors. Mol Cell Biol 20:3817-3830.
2. Arcaro A, Khanzada UK, Vanhaesebroeck B, Tetley TD, Waterfield MD, Seckl MJ. 2002. Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO J 21:5097-5108.
3. Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. 2004. Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts. J Immunol 172:7123-7135.
4. Aspenstrom P, Fransson A, Saras J. 2004. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem J 377:327-337.
5. Baumeister MA, Martinu L, Rossman KL, Sondek J, Lemmon MA, Chou MM. 2003. Loss of phosphatidylinositol 3-phosphate binding by the C-terminal Tiam-1 pleckstrin homology domain prevents in vivo Rac1 activation without affecting membrane targeting. J Biol Chem 278:11457-11464.
6. Boeddinghaus C, Merz AJ, Laage R, Ungermann C. 2002. A cycle of Vam7p release from and PtdIns 3-P-dependent rebinding to the yeast vacuole is required for homotypic vacuole fusion. J Cell Biol 157:79-89.
7. Brakebusch C, Fassler R. 2003. The integrin-actin connection, an eternal love affair. EMBO J 22:2324-2333.
8. Brown RA, Ho LK, Weber-Hall SJ, Shipley JM, Fry MJ. 1997. Identification and cDNA cloning of a novel mammalian C2 domain-containing phosphoinositide 3-kinase, HsC2-PI3K. Biochem Biophys Res Commun 233:537-544.
9. Burd CG, Emr SD. 1998. Phosphatidylinositol (3)-phosphate signalling mediated by specific binding to RING FYVE domains. Mol Cell 2:157-162.
10. Cantley LC, Neel BG. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240-4245.
11. Crljen V, Volinia S, Banfic H. 2002. Hepatocyte growth factor activates phosphoinositide 3-kinase C2beta in renal brush-border plasma membranes. Biochem J 365:791-799.
12. Dib K, Melander F, Axelsson L, Dagher MC, Aspenstrom P, Andersson T. 2003. Down-regulation of Rac activity during beta 2 integrin-mediated adhesion of human neutrophils. J Biol Chem 278:24181-24188.
13. Domin J, Waterfield MD. 1997. Using structure to define the function of phosphoinositide 3-kinase family members. FEBS Lett 410:91-95.
14. Domin J, Pages F, Volinia S, Rittenhouse SE, Zvelebil MJ, Stein RC, Waterfield MD. 1997. Cloning of a human phosphatidylinositol 3-kinase with a C2 domain which displays reduced sensitivity to the inhibitor wortmannin. Biochem J 326:139-147.
15. Ellson CD, Anderson KE, Morgan G, Chilvers ER, Lipp P, Stephens LR, Hawkins PT. 2001. Phosphatidylinositol 3-phosphate is generated in phagosomal membranes. Curr Biol 11:1631-1635.
16. Estrada L, Caron E, Gorski JL. 2001. Fgd1, the Cdc42 guanine nucleotide exchange factor responsible for faciogenital dysplasia, is localized to the subcortical actin cytoskeleton and Golgi membrane. Hum Mol Genet 10:485-495.
17. Etienne-Manneville S, Hall A. 2001. Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 106:489-498.
18. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420:629-635.
19. Funamoto S, Meili R, Lee S, Parry L, Firtel RA. 2002. Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 109:611-623.
20. Gaullier JM, Simonsen A, D'Arrigo A, Bremnes B, Stenmark H, Aasland R. 1998. FYVE Fingers bind PtdIns(3)P. Nature 394:432-433.
21. Huang YE, Iijima M, Parent CA, Funamoto S, Firtel RA, Devreotes P. 2003. Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells. Mol Biol Cell 14:1913-1922.
22. Ignatoski KM, Maehama T, Markwart SM, Dixon JE, Livant DL, Ethier SP. 2000. ERBB-2 overexpression confers PI 3′ kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer 82:666-674.
23. Insall RH, Weiner OD. 2001. PIP3, PIP2, and cell movement-Similar messages, different meanings? Dev Cell 1:743-747.
24. Itoh F, Divecha N, Brocks L, Oomen L, Janssen H, Calafat J, Itoh S, Dijke PP. 2002. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/ Smad signalling. Genes Cells 7:321-331.
25. Komoriya A, Green LJ, Mervic M, Yamada SS, Yamada KM, Humphries MJ. 1991. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem 266:15075-15079.
26. Laporte J, Blondeau F, Gansmuller A, Lutz Y, Vonesch JL, Mandel JL. 2002. The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J Cell Sci 115:3105-3117.
27. Leemhuis J, Boutillier S, Barth H, Feuerstein TJ, Brock C, Nurnberg B, Aktories K, Meyer DK. 2004. Rho GTPases and phosphoinositide 3-kinase organize formation of branched dendrites. J Biol Chem 279:585-596.
28. Leevers SJ, Vanhaesebroeck B, Waterfield MD. 1999. Signalling through phosphoinositide 3-kinases: The lipids take centre stage. Curr Opin Cell Biol 11:219-225.
29. Maehama T, Taylor GS, Dixon JE. 2001. PTEN and myotubularin: Novel phosphoinositide phosphatases. Annu Rev Biochem 70:247-279.
30. Maffucci T, Brancaccio A, Piccolo E, Stein RC, Falasca M. 2003. Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. Embo J 22:4178-4189.
31. Merlot S, Firtel RA. 2003. Leading the way: Directional sensing through phosphatidylinositol 3-kinase and other signaling pathways. J Cell Sci 116:3471-3478.
32. Nobes CD, Hawkins P, Stephens L, Hall A. 1995. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J Cell Sci 108(Pt 1):225-233.
33. Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, Smith AJ, Vanhaesebroeck B. 2002. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297:1031-1034.
34. Ono F, Nakagawa T, Saito S, Owada Y, Sakagami H, Goto K, Suzuki M, Matsuno S, Kondo H. 1998. A novel class II phosphoinositide 3-kinase predominantly expressed in the liver and its enhanced expression during liver regeneration. J Biol Chem 273:7731-7736.
35. Ono Y, Nakanishi H, Nishimura M, Kakizaki M, Takahashi K, Miyahara M, Satoh-Horikawa K, Mandai K, Takai Y. 2000. Two actions of frabin: Direct activation of Cdc42 and indirect activation of Rac. Oncogene 19:3050-3058.
36. Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S. 2000. Activation of synovial fibroblasts in rheumatoid arthritis: Lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2:59-64.
37. Papayannopoulou T, Craddock C. 1997. Homing and trafficking of hemopoietic progenitor cells. Acta Haematol 97:97-104.
38. Pasteris NG, Cadle A, Logie LJ, Porteous ME, Schwartz CE, Stevenson RE, Glover TW, Wilroy RS, Gorski JL. 1994. Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: A putative Rho/Rac guanine nucleotide exchange factor. Cell 79:669-678.
39. Pollard TD. 2003. The cytoskeleton, cellular motility and the reductionist agenda. Nature 422:741-745.
40. Raftopoulou M, Hall A. 2004. Cell migration: Rho GTPases lead the way. Dev Biol 265:23-32.
41. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A. 2004. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303:1179-1181.
42. Razzini G, Brancaccio A, Lemmon MA, Guarnieri S, Falasca M. 2000. The role of the pleckstrin homology domain in membrane targeting and activation of phospholipase Cbeta(1). J Biol Chem 275:14873-14881.
43. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. 2003. Cell migration: Integrating signals from front to back. Science 302:1704-1709.
44. Royal I, Lamarche-Vane N, Lamorte L, Kaibuchi K, Park M. 2000. Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol Biol Cell 11:1709-1725.
45. Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F, Collard JG. 1998. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol 143:1385-1398.
46. Schu PV, Takegawa K, Fry MJ, Stack JH, Waterfield MD, Emr SD. 1993. Phosphatidylinositol 3-kinase encoded by the yeast VPS34 gene essential for protein sorting. Science 260:88-92.
47. Simonsen A, Wurmser AE, Emr SD, Stenmark H. 2001. The role of phosphoinositides in membrane transport. Curr Opin Cell Biol 13:485-492.
48. Small JV, Rottner K, Kaverina I. 1999. Functional design in the actin cytoskeleton. Curr Opin Cell Biol 11:54-60.
49. Snyder JT, Rossman KL, Baumeister MA, Pruitt WM, Siderovski DP, Der CJ, Lemmon MA, Sondek J. 2001. Quantitative analysis of the effect of phosphoinositide interactions on the function of Dbl family proteins. J Biol Chem 276:45868-45875.
50. Srinivasan S, Wang F, Glavas S, Ott A, Hofmann F, Aktories K, Kalman D, Bourne HR. 2003. Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis. J Cell Biol 160:375-385.
51. Stephens L, Cooke FT, Walters R, Jackson T, Volinia S, Gout I, Waterfield MD, Hawkins PT. 1994a. Characterization of a phosphatidylinositol-specific phosphoinositide 3-kinase from mammalian cells. Curr Biol 4:203-214.
52. Stephens L, Smrcka A, Cooke FT, Jackson TR, Sternweis PC, Hawkins PT. 1994b. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits. Cell 77:83-93.
53. Stephens L, Ellson C, Hawkins P. 2002. Roles of PI3Ks in leukocyte chemotaxis and phagocytosis. Curr Opin Cell Biol 14:203-213.
54. Symons M, Derry JM, Karlak B, Jiang S, Lemahieu V, McCormick F, Francke U, Abo A. 1996. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84:723-734.
55. Toker A, Cantley LC. 1997. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676.
56. Turner SJ, Domin J, Waterfield MD, Ward SG, Westwick J. 1998. The CC chemokine Monocyte Chemotactic Peptide-1 activates both the Class I p85/ p110 Phosphatidylinositol 3-kinase and the Class II PI3K-C2a. J Biol Chem 273:25987-25995.
57. Vanhaesebroeck B, Jones GE, Allen WE, Zicha D, Hooshmand-Rad R, Sawyer C, Wells C, Waterfield MD, Ridley AJ. 1999. Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat Cell Biol 1:69-71.
58. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD. 2001. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602.
59. Vieira OV, Botelho RJ, Rameh L, Brachmann SM, Matsuo T, Davidson HW, Schreiber A, Backer JM, Cantley LC, Grinstein S. 2001. Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J Cell Biol 155:19-25.
60. Welch HC, Coadwell WJ, Stephens LR, Hawkins PT. 2003. Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett 546:93-97.
61. Wheeler M, Domin J. 2001. Recruitment of the class II phosphoinositide 3-kinase C2beta to the epidermal growth factor receptor: Role of Grb2. Mol Cell Biol 21:6660-6667.
62. White ES, Thannickal VJ, Carskadon SL, Dickie EG, Livant DL, Markwart S, Toews GB, Arenberg DA. 2003. Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: A role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med 168:436-442.
63. Zhang J, Banfic H, Straforini F, Tosi L, Volinia S, Rittenhouse S. 1998. A type II phosphoinositide 3-kinase is stimulated via activated integrin in platelets. A source of phosphatidylinositol 3-phosphate. J Biol Chem 273:14081-14084.